Paul Galardy is an Oncology physician affiliated with Mayo Clinic. OpenAlex indexes 99 publications with 3,941 citations (h-index 30).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingNIH funding
1 NIH research award on record, funded 2011–2015 per NIH RePORTER. The latest:
- Exploring the role of the de-ubiquitinase UCH-L1 in B-cell malignancy
Mayo Clinic Rochester
FY2015$327,228R01CA151351 - Exploring the role of the de-ubiquitinase UCH-L1 in B-cell malignancy
Mayo Clinic Rochester
FY2014$317,411R01CA151351 - Exploring the role of the de-ubiquitinase UCH-L1 in B-cell malignancy
Mayo Clinic Rochester
FY2013$317,594R01CA151351
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Bradley Boeve, MD
Mayo Clinic
S Rajkumar, MD
Mayo Clinic
Victor Montori, MD
Mayo Clinic
Ayalew Tefferi, MD
Mayo Clinic
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Beth Karlan, MD
University of California, Los Angeles
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”